London-based digital health startup Your.MD, will announce securing $5m in a seed funding round led by Smedvig Capital with participation from existing angel investors.

This will be one of the largest seed funding rounds raised in the UK's digital health space.

Your.MD is a free app that delivers health information to anyone with a smartphone no matter where they are in the world, giving them help in deciding if they need a General Practitioner (GP) in the first place.

Your.MD:

• Your.MD's Symptom Checker has already advised users on 1.5m symptoms and has been downloaded more than 500,000 times since launching in April 2014

• Already working with many of the world's leading health organisations, including the NHS

• The app is already available on over 400m devices after partnering with Samsung in its S-Health offering in November 2014

As Tullow Oil report its H1 figures, Graham Spooner, investment research analyst at The Share Centre, explains what they means for investors.

Tullow oil offers contrarian investors exposure to any longer term oil price recovery

• Production increased 4% on the same period last year
• Positive exploration and production in East and West Africa

As Tullow Oil report its H1 figures, Graham Spooner, investment research analyst at The Share Centre, explains what they means for investors.

"Despite declining profits in the first half of the year, this morning Tullow Oil reported an encouraging trading update with production increasing 4% on the same period last year.

"Tullow Oil has felt the pain of the plunge in the price of oil, as revenue fell by 38% to $800m. The company has taken steps to offset this and is targeting cost saving in the coming year. We feel positive about the good progress reported in its West African projects, where guidance for the remainder of the year has increased to 66,000 - 70,000 barrels of oil per day. Looking forward for investors, exploration projects in East Africa have also shown good results and are supported by the governments in Kenya and Uganda.

"We currently recommend Tullow Oil as a 'buy' for contrarian investors, willing to accept a higher level of risk. The stock is highly geared to the oil price, and will benefit from any longer term recovery."

Persimmon figures in-line with market expectations as consumer confidence grows

• The UK house builder reports a revenue increase of 12%

• Demand in the property sector remains strong which should benefit the group

 As Persimmon reports this morning, Helal Miah, investment research analyst at The Share Centre, explains what it mean for investors.

"This morning, Persimmon's first half trading figures proved to be in-line with expectations and continue to reflect the buoyant market for new homes. Total revenues increased by 12% to £1.34bn, as legal completions rose by 7%, while the average selling price for each home rose by 4% to £195,000.

"Investors should acknowledge that visitor numbers remain high, similar to last year's levels, while customer demand has been supported by an increasingly competitive mortgage market. Despite the slowdown in planning applications prior to the general election, the group still opened a further 122 new sites taking the network of active sites to 395 across the country.

"Going forward, the house builder is looking to open another 125 new development sites during the second half of the year and is actively looking to strengthen the land bank. We believe this strategy is in-line with the ongoing strong demand for housing as the UK economy and population grows. We currently recommend Persimmon as a 'hold' for medium risk investors seeking growth, but would not discourage investors buying on dips in the share price. However, our preferences in the sector are Taylor Wimpey and Berkeley Group."